GlassScriptPhysician profile
Alisa Kraft
NPI 1235729534
$6,734.04
in general payments reported to CMS, 2019-2025
52 companies · $1,783 in 2025
The $1,783 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $687 · 2023: $2,045 · 2024: $2,219 · 2025: $1,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,730 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,730.26 |
| Education | $316.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $693.78 | 2022-2025 | Imfinzi, Calquence, Enhertu |
| Incyte Corporation | $466.99 | 2022-2025 | Jakafi, Monjuvi, Zynyz |
| Novartis Pharmaceuticals Corporation | $445.71 | 2022-2025 | Kisqali |
| Janssen Biotech, INC. | $426.29 | 2022-2025 | Rybrevant, Erleada, Akeega |
| Merck Sharp & Dohme LLC | $413.65 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Eisai INC. | $280.53 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $278.67 | 2022-2025 | |
| Genentech USA, INC. | $251.17 | 2023-2025 | Alecensa, Tecentriq, Phesgo |
| Ipsen Biopharmaceuticals, INC | $246.42 | 2022-2025 | Onivyde, Tazverik |
| Takeda Pharmaceuticals U.S.A., INC. | $228.80 | 2022-2025 | Fruzaqla, Iclusig, Alunbrig |
| Daiichi Sankyo INC. | $198.27 | 2023-2025 | Enhertu, Injectafer |
| Seagen INC. | $187.05 | 2022-2023 | Adcetris, Tukysa |
| E.R. Squibb & Sons, L.L.C. | $164.78 | 2023-2024 | Opdivo |
| Lilly USA, LLC | $152.26 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Emd Serono, INC. | $145.63 | 2022-2024 | Bavencio |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $145.16 | 2023-2025 | Xpovio |
| Regeneron Healthcare Solutions, INC. | $116.22 | 2022-2025 | Libtayo |
| Springworks Therapeutics, INC. | $114.85 | 2024-2025 | Ogsiveo |
| Pfizer INC. | $110.88 | 2023-2025 | |
| Astellas Pharma US INC | $107.97 | 2023-2024 | Vyloy, Xospata |
| Telix Pharmaceuticals | $100.00 | 2025 | Illuccix |
| Amgen INC. | $95.42 | 2022-2023 | Kyprolis, Blincyto, Nplate |
| Tersera Therapeutics LLC | $95.16 | 2023-2025 | Zoladex, Xermelo |
| Agios Pharmaceuticals, INC. | $87.55 | 2023-2025 | Pyrukynd |
| Celgene Corporation | $84.05 | 2025 | Opdivo, Opdualag, Reblozyl |
| Taiho Oncology, INC. | $83.93 | 2022-2023 | |
| Puma Biotechnology, INC. | $73.46 | 2023-2024 | |
| Glaxosmithkline, LLC. | $67.60 | 2023-2025 | Jemperli, Zejula |
| Adc Therapeutics America, INC. | $64.74 | 2022-2025 | |
| Exelixis INC. | $59.88 | 2022-2023 | Cabometyx |
| Abbvie INC. | $53.65 | 2024-2025 | |
| Gilead Sciences, INC. | $53.05 | 2023-2025 | Trodelvy |
| Genzyme Corporation | $48.80 | 2023-2024 | |
| Stemline Therapeutics INC. | $48.59 | 2024-2025 | Orserdu, Elzonris |
| Mirati Therapeutics, INC. | $46.28 | 2023 | Krazati |
| Beigene USA, INC. | $44.88 | 2023 | Brukinsa |
| Amneal Pharmaceuticals LLC | $39.86 | 2023 | Avastin |
| Genmab U.S., INC. | $39.44 | 2023-2024 | Epkinly |
| Acrotech Biopharma INC. | $35.38 | 2022-2024 | Beleodaq |
| Servier Pharmaceuticals LLC | $35.37 | 2023-2025 | |
| Deciphera Pharmaceuticals INC. | $34.63 | 2024-2025 | Qinlock |
| Beone Medicines USA, INC. | $33.66 | 2025 | Brukinsa |
| Sun Pharmaceutical Industries INC. | $31.72 | 2025 | |
| Alexion Pharmaceuticals, INC. | $29.29 | 2023 | Ultomiris |
| Cti Biopharma Corp. | $26.90 | 2022 | |
| Kite Pharma, INC. | $24.35 | 2025 | Yescarta |
| Adaptive Biotechnologies Corporation | $22.84 | 2025 | Clonoseq |
| Pharmaessentia USA Corporation | $22.42 | 2022 | |
| G1 Therapeutics, INC. | $20.06 | 2023 | Cosela |
| Sobi, INC | $19.64 | 2024 | |
| Immunocore Limited | $19.30 | 2024 | Kimmtrak |
| Syndax Pharmaceuticals, INC. | $17.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisa Kraft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.